Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions. In this article, we will take a closer look at the causes and treatment options for trichofolliculoma.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions.
The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. The abnormal hair follicle is thought to be caused by a combination of genetic and environmental factors. It is believed that the abnormal hair follicle is caused by a mutation in the gene that controls the growth and development of hair follicles. This mutation causes the hair follicle to become enlarged and develop a central pore from which hairs emerge.
Trichofolliculoma is typically diagnosed by a physical exam. The doctor will examine the skin for the characteristic dome-shaped bump with a central pore from which hairs emerge. The doctor may also order additional tests such as a biopsy to confirm the diagnosis.
The treatment for trichofolliculoma typically involves surgical removal of the tumor. The procedure is usually done under local anesthesia and is usually successful in removing the entire tumor. In some cases, the tumor may recur and require additional surgery. In some cases, the doctor may recommend a topical cream or ointment to reduce the size of the tumor. These creams and ointments typically contain retinoids or corticosteroids, which are medications that can reduce inflammation and shrink the tumor. In rare cases, the doctor may recommend radiation therapy to shrink the tumor. This is usually done if the tumor is large or if it is not responding to other treatments.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. Trichofolliculoma is typically diagnosed by a physical exam and is usually treated with surgical removal of the tumor. In some cases, topical creams or ointments may be used to reduce the size of the tumor or radiation therapy may be recommended.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
3.
Rural-urban disparities seen in cervical cancer
4.
Obesity linked to subsequent neoplasms in childhood cancer survivors
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Is AI The New Radiologist For Breast MRI?
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation